Hemlibra New Zealand - English - Medsafe (Medicines Safety Authority)

hemlibra

roche products (nz) ltd - emicizumab 150 mg/ml - solution for injection - 150 mg/ml - active: emicizumab 150 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Hemlibra New Zealand - English - Medsafe (Medicines Safety Authority)

hemlibra

roche products (nz) ltd - emicizumab 30 mg/ml - solution for injection - 30 mg/ml - active: emicizumab 30 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

HEMLIBRA emicizumab (rch) 60 mg/0.4 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hemlibra emicizumab (rch) 60 mg/0.4 ml solution for injection vial

roche products pty ltd - emicizumab, quantity: 60 mg - injection, solution - excipient ingredients: poloxamer; arginine; aspartic acid; water for injections; histidine - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hemlibra emicizumab (rch) 30 mg/1 ml solution for injection vial

roche products pty ltd - emicizumab, quantity: 30 mg - injection, solution - excipient ingredients: arginine; water for injections; histidine; aspartic acid; poloxamer - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

HEMLIBRA emicizumab (rch) 150 mg/1 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hemlibra emicizumab (rch) 150 mg/1 ml solution for injection vial

roche products pty ltd - emicizumab, quantity: 150 mg - injection, solution - excipient ingredients: aspartic acid; histidine; arginine; poloxamer; water for injections - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hemlibra emicizumab (rch) 105 mg/0.7 ml solution for injection vial

roche products pty ltd - emicizumab, quantity: 105 mg - injection, solution - excipient ingredients: arginine; poloxamer; aspartic acid; histidine; water for injections - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Pradaxa Australia - English - Department of Health (Therapeutic Goods Administration)

pradaxa

boehringer ingelheim pty ltd - dabigatran etexilate mesilate -

Medicine administration kit, percutaneous, medicated, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

medicine administration kit, percutaneous, medicated, single-use

baxalta australia pty ltd -

Medicine administration kit, percutaneous, non-medicated, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

medicine administration kit, percutaneous, non-medicated, single-use

baxalta australia pty ltd -

Transfer set, fluid Australia - English - Department of Health (Therapeutic Goods Administration)

transfer set, fluid

baxalta australia pty ltd -